Swiggy’s ₹10,000 Cr Reload & The Great IPO Disconnect: Why Dalal Street is Bleeding but the Primary Market is Partying

Disclaimer: This article is for informational purposes only and does not constitute financial advice.

TL;DR

The Market Split: Sensex is down 600+ points due to US Fed fears and FII selling, yet the IPO market is breaking records.
Swiggy’s Power Move: Swiggy has launched a ₹10,000 Cr QIP (Floor Price: ₹390.51) to fight Blinkit and Zepto. Demand was 4.5x.
IPO Reality Check: Corona Remedies is the new darling (134x subscribed, GMP ₹270), while Wakefit is struggling (GMP ₹0). Choose wisely.
Zomato Impact: Swiggy’s cash pile means the Quick Commerce war will get expensive. Expect margin pressure on Zomato.
Strategy: Avoid ‘listing pop’ traps in low-GMP IPOs; use the market dip to accumulate banking blue-chips.

While Sensex sheds 600 points on Fed fears, Swiggy raises a war chest and Corona Remedies sees 130x subscription. Here is how to navigate this schizophrenic market.

The Tale of Two Markets: Why Your Portfolio is Red but the IPO Queue is Green

Wednesday, 10 December 2025

Let’s be honest. If you looked at your portfolio app today, you probably wanted to throw your phone across the room.

The Sensex is down over 400 points, Nifty is struggling to hold 25,800, and it feels like the bears are having a picnic on Dalal Street.

But if you switch tabs to your IPO allotment status? It’s a completely different universe.

While the secondary market is shivering in fear of tonight’s US Fed policy and “Trump Tariffs” on rice, the primary market is partying like it’s 2021.

Meesho just listed with a massive 46% gain. Corona Remedies is being subscribed to like it’s free gold (over 130x!), and Swiggy just passed the hat around to big institutional investors and collected a cool ₹10,000 Crore in what feels like minutes.

Here is the deal: We are witnessing a classic “Liquidity Disconnect.” Foreign investors (FIIs) are selling old stocks, but Domestic investors (DIIs) and Mutual Funds are pumping cash into new stories.

As an investor, you need to know which queue to stand in.

Let’s break down the madness of today, December 10, and figure out how to save your capital.

1. Swiggy’s ₹10,000 Crore War Chest: The “Quick” War Just Got Expensive

While you were debating whether to order lunch from Zomato or Swiggy, Swiggy was busy securing its future. Yesterday, they launched a Qualified Institutional Placement (QIP) with a floor price of ₹390.51.

[Key Insight] What is a QIP? Think of it as a VIP entrance for big investors. Instead of doing another public IPO, a listed company invites Mutual Funds and Banks to buy fresh shares quickly. It dilutes your shareholding slightly but gives the company instant cash.

The Numbers You Need to Know:

Amount Raised: ₹10,000 Crore ($1.1 Billion).
Floor Price: ₹390.51 (Likely issued at a ~4-5% discount, around ₹375).
Demand: Oversubscribed 4.5 times within an hour.
Who Bought In? The heavy hitters—SBI Mutual Fund, ICICI Prudential, HDFC MF, and Kotak.

Why Does This Matter to You? If you hold Zomato or Swiggy, this is a signal. Swiggy isn’t raising this money to pay electricity bills. They are raising it to fight the Quick Commerce War (Instamart vs. Blinkit vs. Zepto).

This money will go into building more “Dark Stores” (those tiny warehouses in your neighborhood) and offering deeper discounts.

For Zomato shareholders, this is a warning: Profit margins might come under pressure soon. When your rival has ₹10,000 Cr in the bank, they can afford to bleed to win market share.

My Take: The fact that top Indian Mutual Funds oversubscribed it 4.5x tells me they believe the stock is undervalued near its IPO price of ₹390. If the big boys are buying at ₹375-390, the downside risk from here seems limited.

2. The IPO Finale: Corona vs. Wakefit

Today is the final day to bid for two very different IPOs. This is the perfect example of why you shouldn’t just apply for everything blindly.

The Hot Cake: Corona Remedies

This Pharma company is the star of the week.

Subscription: Over 134x (NIIs went crazy with 200x+).
GMP (Grey Market Premium): Holding strong at ₹270 (approx 25-29% profit).
The Vibe: It’s a solid business with decent financials. The market loves Pharma right now because it’s a “defensive” sector—when the economy looks shaky, people still buy medicines.

[Pro Tip] If you applied for Corona Remedies, pray to your favorite deity. With subscription levels this high, allotment is a lottery. If you get it, HOLD for the listing pop, but don’t chase it if it lists at a crazy 50% premium on Monday.

The Cold Shoulder: Wakefit Innovations

I love their mattresses (I’m sure many of you sleep on one), but the stock market is not a bedroom.

Subscription: Struggling to cross 1x comfortably (Retail is carrying it, QIBs are hesitant).
GMP: Crashed to ₹0 - ₹2. Basically, flat.
The Risk: A GMP of zero means the “grey market” thinks there is no profit left on the table. If the market sentiment worsens by listing day (Dec 15), this could open at a discount.

[Warning] Retail Trap Alert: Retail investors have subscribed 2.4x to Wakefit while “Smart Money” (QIBs) stayed away until the last minute. When retail is bullish and institutions are bearish, it’s usually a sign to stay away. Don’t be the one holding the bag.

3. Why is the Market Bleeding Today? (Sensex -600 pts)

If IPOs are so hot, why is your portfolio red? The Sensex and Nifty are down for the third straight day. Here is the cocktail of bad news:

The US Fed Nerves: Chairman Jerome Powell speaks tonight. The market is terrified he might say, “No rate cuts in 2026.” If interest rates stay high in the US, money flows out of emerging markets like India.
FII Selling Spree: Foreign investors sold over ₹3,760 Crore yesterday alone. They are packing their bags and moving money to the US or China.
Trump Tariffs: There are fresh rumors/reports about potential US tariffs on Indian rice. It’s a specific commodity, but it spooks the entire sentiment around trade.

The Silver Lining: Domestic Institutions (DIIs) bought ₹6,225 Crore worth of shares yesterday. They are literally the only thing stopping a total crash.

4. Applied Strategy: What Should You Do Now?

You can’t control the Fed, and you can’t control Swiggy’s fundraising. But you can control your trades. Here is my 3-step action plan for today:

Step 1: The “Sniper” Approach to IPOs Stop applying for every SME and Mainboard IPO. The easy money era is fading.

Action: If you bid for Wakefit, check if you can cancel/withdraw if you are risk-averse. The 0 GMP is a massive red flag.
Action: Keep cash ready for Corona Remedies (if you get lucky) or wait for the next quality issue.

Step 2: Accumulate the “Guilt-Free” Stocks When FIIs sell, they sell liquid, high-quality stocks first because they are easy to sell. This depresses the prices of good companies unfairly.

Sector Watch: Private Banks (HDFC/ICICI). They are posting record profits but are trading at average valuations because FIIs are selling them.
Strategy: Use this dip (Nifty below 25,800) to start a SIP in a Banking ETF or blue-chip bank stocks. You will thank yourself in 6 months.

Step 3: Watch the “Quick Commerce” Space With Swiggy reloaded, Zomato might see some volatility.

Trade: If Zomato falls below ₹200 (psychological support), it might be a good entry for long-term believers. But expect the next 2 quarters to be “noisy” as they spend money to fight Swiggy.

[Bottom Line] The market is schizophrenic right now. It loves new shiny things (IPOs) but hates established players (Nifty 50). Don’t get distracted by the IPO party noise.

Real wealth is made by buying quality secondary stocks when everyone else is panic-selling.

Stay safe, trade smart, and maybe check your IPO allotment status before checking your portfolio today!

Frequently Asked Questions (FAQ)

Q: Why is Swiggy raising ₹10,000 Crore just one year after IPO? A: To fight the competition. Quick Commerce (10-minute delivery) burns a lot of cash. Competitors like Zepto and Blinkit are aggressive. Swiggy needs this cash to expand its “Instamart” dark stores and offer discounts without running out of money.

Q: Is Wakefit IPO safe to buy for listing gains? A: It looks risky. The Grey Market Premium (GMP) has dropped to almost zero. Institutional interest (QIB) was low for most of the bidding period. This suggests limited upside on listing day.

Q: Why is the Indian stock market falling in December 2025? A: It is a mix of global fears (US Fed interest rate decision), heavy selling by Foreign Investors (FIIs), and year-end profit booking. The Nifty has broken key support levels, causing technical selling as well.

Q: How do I check Corona Remedies IPO Allotment status? A: The allotment will be finalized tomorrow (Dec 11). You can check it on the registrar’s website (Bigshare Services) or on the BSE/NSE website using your PAN card number.

Impact on Indian Stock Market

Positive Impact

Pharma: Corona Remedies IPO success shows massive investor appetite for healthcare defensive stocks.
Quick Commerce (Swiggy): Successfully raised ₹10,000 Cr from top Mutual Funds, validating their business model and securing growth capital.

Negative Impact

IT & Tech: High sensitivity to US Fed rates; Nifty IT index is dragging the market down today.
Aviation (IndiGo): Government ordered a 10% flight cut due to cancellations, causing the stock to fall ~3%.

Neutral Impact

Banking: Strong DII buying is countering FII selling, keeping the sector relatively stable despite the broader crash.

The Final Word

Today’s market action is a reminder that “Price is what you pay, Value is what you get.” In the IPO market, people are paying premium prices for hope (Corona, Meesho).

In the secondary market, people are selling value (Banks, IT) out of fear.

As we head into the second half of December, liquidity will dry up as global fund managers go on holiday. Expect volatility to remain high.

My advice? If you got the Swiggy signal (Institutions buying at ₹390), trust the smart money. If you are chasing Wakefit despite the red flags, you are gambling, not investing. Keep your powder dry—2026 is just around the corner, and entry points are getting attractive.

Swiggy’s ₹10,000 Cr Reload & The Great IPO Disconnect: Why Dalal Street is Bleeding but the Primary Market is Partying